Key Terms
clinical-stage
medical
Clinical-stage describes a drug, therapy, or company whose product is being tested in human trials but has not yet received regulatory approval. For investors, it signals that the project has moved beyond lab work into real-world testing—meaning higher potential reward if trials succeed but also clear risks from trial setbacks, costs, and regulatory delay; think of it like a prototype car on public road tests that could either prove its value or reveal problems that stop it from reaching production.
protein engineering
medical
Protein engineering is the deliberate design and modification of proteins to change how they behave—making them more stable, more active, or targeted for a specific task—so they can be used as medicines, industrial enzymes, or diagnostic tools. For investors it matters because successful engineering can turn a lab method into a marketable product, much like customizing a tool for a new job: it can increase value and reduce development risk, but also carries technical and regulatory uncertainty.
clinical workflow automation
medical
Clinical workflow automation is software that streamlines routine tasks in healthcare settings—such as scheduling, test ordering, medication reminders, and documentation—so clinicians and staff can follow standardized, automated steps instead of doing repetitive work by hand. For investors, it matters because automation can lower operating costs, reduce errors, increase patient throughput and satisfaction, and create scalable revenue opportunities for vendors in a large, regulated market; think of it as installing an automated assembly line in a hospital.
capital markets
financial
Capital markets are places where people and organizations buy and sell long-term investments like stocks and bonds. They help connect those who need money to grow or fund projects with investors looking to earn returns over time. For investors, capital markets are important because they offer opportunities to invest, save, and grow their wealth through a variety of financial assets.
personalized spine surgery
medical
Personalized spine surgery is an approach that tailors the surgical plan, implants and tools to an individual patient’s anatomy and condition—often using detailed imaging, custom-made implants or patient-specific guides—rather than a one-size-fits-all procedure. For investors, it matters because personalized techniques can improve outcomes, shorten recovery and create demand for premium devices, software and services, which can shift market size, pricing and regulatory risk in the spine-care industry.
AI integration
technical
The adoption of artificial intelligence tools and systems into a company’s products, services, or internal operations to automate tasks, analyze data, or improve decision-making. For investors, AI integration can change a business’s cost structure, speed, and competitive edge—like adding a faster, smarter engine to a car—potentially boosting revenue or efficiency but also introducing execution, data, and regulatory risks that can affect future profits.
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Dan Wolf as a managing director in the healthcare investment banking group. Wolf will be based in the
“Dan is a highly respected med tech executive with an impressive track record of advising healthcare technology companies through complex transactions. His experience and strong relationships will further enhance our ability to serve clients as they navigate strategic opportunities and transformative deals,” said J.P. Peltier, global co-head of investment banking and capital markets at Piper Sandler.
“I’m excited to join the Piper Sandler healthcare investment banking team at a pivotal time for the industry. Healthcare technology companies are navigating increasingly complex strategic decisions around AI integration, clinical workflow automation and market consolidation. I look forward to partnering with management teams and boards to help them achieve their strategic objectives through thoughtful M&A advice and capital markets expertise,” said Wolf.
Wolf returns to Piper Sandler where he began his career as a healthcare investment banking analyst. He brings over 20 years of healthcare experience spanning investment banking, operating leadership and strategic advisory. Prior to rejoining the firm, he served as chief financial officer at Theradaptive, a clinical-stage protein engineering company. He also founded Convergence Bio Advisors, where he advised healthcare companies, boards and private equity firms on M&A transactions. Before that, Wolf was senior vice president and chief strategy officer at Baxter International, leading global strategic planning, portfolio management and corporate development activities. He previously spent 12 years at Medtronic in roles of increasing responsibility, including vice president and general manager of intelligent data solutions where he led the company’s digital transformation and expansion into personalized spine surgery.
Wolf received a bachelor’s degree in economics and mathematics from
ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the
Follow Piper Sandler: LinkedIn | Facebook | X
©2026. Since 1895. Piper Sandler Companies. 800 Nicollet Mall,
View source version on businesswire.com:
Nick Lawler
Tel: 212 891-8954
[email protected]
Source: Piper Sandler Companies
link
More Stories
Symposium on International Investment Law & Contemporary Crises: Do Investment Treaties Accord Too Much (or Too Little) Protection to Banking and Finance Investments?
PrimeRx Has Been Acquired by RedSail Transaction
Breaking Barriers: How Two WashU Scholar-Champions are Revolutionizing Investment Banking Recruitment with AI